Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | STRADB (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STRADB mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Stradb (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of STRADB mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Stradb (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of STRADB mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Stradb (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STRADB mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of STRADB mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of STRADB mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of STRADB mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of STRADB mRNA | CTD | PMID:21215274 and PMID:21724226 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Stradb (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of STRADB mRNA | CTD | PMID:21570461 | 4-hydroxynon-2-enal | decreases expression | ISO | Stradb (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of STRADB mRNA | CTD | PMID:19191707 | aflatoxin B1 | decreases methylation | ISO | STRADB (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of STRADB gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of STRADB mRNA | CTD | PMID:33167477 | aristolochic acid A | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of STRADB mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases methylation | ISO | Stradb (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of STRADB exon and Benzo(a)pyrene results in increased methylation of STRADB intron | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | STRADB (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of STRADB 5' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of STRADB mRNA | CTD | PMID:25181051 more ... | cadmium atom | multiple interactions | ISO | STRADB (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of STRADB mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | STRADB (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of STRADB mRNA | CTD | PMID:35301059 | caffeine | decreases phosphorylation | ISO | STRADB (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of STRADB protein | CTD | PMID:35688186 | cannabidiol | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of STRADB mRNA | CTD | PMID:27714895 | CGP 52608 | multiple interactions | ISO | STRADB (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to STRADB gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Stradb (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of STRADB mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Stradb (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STRADB mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STRADB gene | CTD | PMID:20938992 | cisplatin | multiple interactions | ISO | STRADB (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of STRADB mRNA | CTD | PMID:27392435 | cisplatin | increases expression | ISO | STRADB (Homo sapiens) | 6480464 | Cisplatin results in increased expression of STRADB mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of STRADB mRNA | CTD | PMID:19549813 | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of STRADB mRNA | CTD | PMID:36653537 | dioxygen | multiple interactions | ISO | Stradb (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STRADB mRNA | CTD | PMID:30529165 | doxorubicin | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of STRADB mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of STRADB mRNA | CTD | PMID:29391264 | epoxiconazole | increases expression | ISO | Stradb (Mus musculus) | 6480464 | epoxiconazole results in increased expression of STRADB mRNA | CTD | PMID:35436446 | folic acid | multiple interactions | ISO | Stradb (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of STRADB mRNA | CTD | PMID:33387578 | glafenine | decreases expression | EXP | | 6480464 | Glafenine results in decreased expression of STRADB mRNA | CTD | PMID:24136188 | hydrogen peroxide | increases expression | ISO | STRADB (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of STRADB mRNA | CTD | PMID:18951874 | L-methionine | multiple interactions | ISO | Stradb (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STRADB mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STRADB gene | CTD | PMID:20938992 | leflunomide | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | leflunomide results in decreased expression of STRADB mRNA | CTD | PMID:28988120 | methylmercury chloride | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of STRADB mRNA | CTD | PMID:28001369 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of STRADB mRNA | CTD | PMID:25729387 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of STRADB mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | STRADB (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of STRADB mRNA | CTD | PMID:35430440 | paracetamol | affects expression | ISO | Stradb (Mus musculus) | 6480464 | Acetaminophen affects the expression of STRADB mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of STRADB mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Stradb (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of STRADB mRNA | CTD | PMID:36331819 | potassium chromate | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of STRADB mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | STRADB (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STRADB mRNA | CTD | PMID:22079256 | potassium dichromate | decreases expression | ISO | Stradb (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of STRADB mRNA | CTD | PMID:23608068 | sunitinib | increases expression | ISO | STRADB (Homo sapiens) | 6480464 | Sunitinib results in increased expression of STRADB mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | STRADB (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of STRADB mRNA | CTD | PMID:31758290 | tetrachloromethane | increases expression | ISO | Stradb (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of STRADB mRNA | CTD | PMID:17484886 | tetrachloromethane | decreases expression | ISO | Stradb (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of STRADB mRNA | CTD | PMID:31919559 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of STRADB mRNA | CTD | PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of STRADB mRNA | CTD | PMID:25729387 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of STRADB mRNA | CTD | PMID:25729387 | valproic acid | affects expression | ISO | Stradb (Mus musculus) | 6480464 | Valproic Acid affects the expression of STRADB mRNA | CTD | PMID:17292431 | |